A French research group genetically modified the live attenuated P. aeruginosa strains as vaccine vectors that directly deliver tumor antigens to APCs via T3SS injection and trigger antigen-specific CD8+ T cell responses systemically, leading to long-lasting anti-tumor immune responses (59, 60, 68, 69). Here, CD8A is linked to neoplasm.